Andere Sprachen Vericel Corporation

Aktien

A12FU4

US92346J1088

VCEL

Pharmazeutika

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 13.01.2026			% 5 Tage	Veränd. 1. Jan.
37.05 ^USD	+1.26%		-5.82%	+2.89%

13.01.	Vericel Corporation gibt vorläufige, ungeprüfte Gewinnprognose für das vierte Quartal und das Gesamtjahr 2025 bekannt	CI
13.01.	Vericel meldet vorläufigen Nettoumsatz für 2025	MT

Andere Sprachen

13.01.	Vericel : Presentation JPMorgan Healthcare Conference January 14, 2026 FINAL No Speaker Notes
13.01.	Vericel Corporation Provides Preliminary Unaudited Earnings Guidance for the Fourth Quarter and Full Year of 2025
13.01.	Vericel Reports Preliminary 2025 Net Revenue
13.01.	(VCEL) Vericel Expects 2025 Total Net Revenue About $276M, vs. FactSet Est of $274.1M
13.01.	Vericel Announces Preliminary 2025 Financial Results and Business Updates
06.01.	Vericel to Present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026
14.11.	Vericel to Present at the Stephens Annual Investment Conference on Thursday, November 20, 2025
06.11.	Vericel Corporation Provides Revenue Guidance for the Year 2025
06.11.	Vericel Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025
06.11.	Vericel Swings to Q3 Earnings, Revenue Rises
06.11.	Earnings Flash (VCEL) Vericel Posts Q3 EPS $0.10, vs. FactSet Est of $0.01 Loss
06.11.	Earnings Flash (VCEL) Vericel Corporation Reports Q3 Revenue $67.5M, vs. FactSet Est of $64.6M
06.11.	Vericel : Q3 2025 Earnings Call Presentation FINAL
06.11.	Sports and burn therapies firm Vericel Q3 revenue beats estimates
06.11.	Vericel Reports Third Quarter 2025 Financial Results
23.10.25	Vericel to Report Third-Quarter 2025 Financial Results on November 6, 2025
18.09.25	North American Morning Briefing : Stocks Poised to Open Higher After Rates Cut -2-
17.09.25	Vericel Shares Lower After BTIG Downgrade
28.08.25	Vericel to Present at the Wells Fargo Healthcare Conference on Thursday, September 4, 2025
31.07.25	Vericel Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025
31.07.25	Vericel Q2 Net Loss Narrows, Revenue Rises; Shares Fall
31.07.25	Vericel Corporation Reaffirms Earnings Guidance for the Year 2025
31.07.25	Vericel : Q2 2025 Earnings Call Presentation FINAL
31.07.25	Biologics company Vericel's Q2 revenue misses expectations
31.07.25	Earnings Flash (VCEL) Vericel Posts Q2 Net Loss $0.01 a Share, vs. FactSet Est of $0.03 Loss

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen MarketScreener Artikel MarketScreener Analysen Trading-Ideen

Andere Sprachen Vericel Corporation

Aktien

A12FU4

US92346J1088

VCEL

Pharmazeutika

Andere Sprachen

Filter